Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1020 of 1,261
  1. US 7608422

    Simian immunodeficiency virus (SIV) molecular clone encoding mutant gag gene lacking inhibitory/instability regions

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 27, 2009 · Expires Oct 22, 2029

    granted
  2. US 7608627

    6-azaindole compound

    Takeda Pharmaceutical Company Limited · Granted Oct 27, 2009 · Expires Oct 22, 2029

    granted
  3. US 7608257

    Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

    ONCOLYTICS BIOTECH INC. · Granted Oct 27, 2009 · Expires Oct 22, 2029

    granted
  4. US 7608409

    Screening assay using G-protein coupled receptor protein OT7T175

    Takeda Pharmaceutical Company Limited · Granted Oct 27, 2009 · Expires Oct 22, 2029

    granted
  5. US 7608272

    Methods and compositions for vaccination of animals with PRRSV antigens with improved immunogenicity

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 27, 2009 · Expires Oct 22, 2029

    granted
  6. US 7608641

    Creatine oral supplementation using creatine hydrochloride salt

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 27, 2009 · Expires Oct 22, 2029

    granted
  7. US 7608253

    Hydrolytically degradable carbamate derivatives of poly (ethylene glycol)

    Nektar Therapeutics · Granted Oct 27, 2009 · Expires Oct 22, 2029

    granted
  8. US 7608449

    Methods and compositions related to high-titer pseudotyped retroviruses

    The Regents of the University of California · Granted Oct 27, 2009 · Expires Oct 22, 2029

    granted
  9. US 7605251

    Compositions and methods for inhibiting expression of the PCSK9 gene

    Alnylam Pharmaceuticals, Inc. · Granted Oct 20, 2009 · Expires Oct 15, 2029

    granted
  10. US 7605290

    Processes for the synthesis of O-desmethylvenlafaxine

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 20, 2009 · Expires Oct 15, 2029

    granted
  11. US 7605131

    EML4-ALK fusion gene

    CUREGENE K.K. · Granted Oct 20, 2009 · Expires Oct 15, 2029

    granted
  12. US 7605161

    Pyridyl derivatives and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Oct 20, 2009 · Expires Oct 15, 2029

    granted
  13. US 7604944

    Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same

    Theravance, Inc. · Granted Oct 20, 2009 · Expires Oct 15, 2029

    granted
  14. US 7604973

    DNA encoding hyaluronan synthase from Pasteurella multocida and methods of use

    The Board of Regents of the University of Oklahoma · Granted Oct 20, 2009 · Expires Oct 15, 2029

    granted
  15. US 7604968

    Microorganisms for the recombinant production of resveratrol and other flavonoids

    Regents of the University of Minnesota · Granted Oct 20, 2009 · Expires Oct 15, 2029

    granted
  16. US 7605125

    DNA-binding polyamide drug conjugates

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 20, 2009 · Expires Oct 15, 2029

    granted
  17. US 7605140

    Regulation of angiogenesis with zinc finger proteins

    Sangamo Biosciences, Inc. · Granted Oct 20, 2009 · Expires Oct 15, 2029

    granted
  18. US 7605127

    Truncated hepatocyte growth factor variant protein HGF/NK2

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 20, 2009 · Expires Oct 15, 2029

    granted
  19. US 7605274

    Carvedilol

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 20, 2009 · Expires Oct 15, 2029

    granted
  20. US 7605270

    Polymorphic forms of (S).-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) benzylcarbamate

    Vertex Pharmaceuticals Incorporated · Granted Oct 20, 2009 · Expires Oct 15, 2029

    granted
  21. US 7604798

    Methods and compositions for importing nucleic acids into cell nuclei

    Northwestern University · Granted Oct 20, 2009 · Expires Oct 15, 2029

    granted
  22. US 7604811

    Oral-intestinal vaccines against diseases caused by enteropathic organisms using antigens encapsulated within biodegradable-biocompatible microspheres

    The United States of America as represented by the Secretary of the Army · Granted Oct 20, 2009 · Expires Oct 15, 2029

    granted
  23. US 7605237

    High affinity human antibodies to human IL-4 receptor

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 20, 2009 · Expires Oct 15, 2029

    granted
  24. US 7605126

    Acylaminoheteroaryl hepatitis C virus protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Oct 20, 2009 · Expires Oct 15, 2029

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.